Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements.
Szumera-Ciećkiewicz A, Rymkiewicz G, Sokół K, Paszkiewicz-Kozik E, Borysiuk A, Poleszczuk J, Bachnio K, Bystydzienski Z, Woroniecka R, Grygalewicz B, Kotarska M, Stańczak M, Owczarek D, Pytlak B, Prochorec-Sobieszek M, Walewski J. Szumera-Ciećkiewicz A, et al. Among authors: sokol k. Int J Lab Hematol. 2020 Aug;42(4):453-463. doi: 10.1111/ijlh.13222. Epub 2020 May 4. Int J Lab Hematol. 2020. PMID: 32364682
PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.
Szumera-Ciećkiewicz A, Poleszczuk J, Kuczkiewicz-Siemion O, Paszkiewicz-Kozik E, Rymkiewicz G, Sokół K, Borysiuk A, Kotarska M, Kawecka M, Owczarek D, Pytlak B, Walewski J, Prochorec-Sobieszek M. Szumera-Ciećkiewicz A, et al. Among authors: sokol k. Pathol Res Pract. 2020 Oct;216(10):153096. doi: 10.1016/j.prp.2020.153096. Epub 2020 Jun 29. Pathol Res Pract. 2020. PMID: 32853965
EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment.
Szumera-CieĆkiewicz A, Poleszczuk J, Paszkiewicz-Kozik E, Rymkiewicz G, SokÓŁ K, Borysiuk A, Kotarska M, Owczarek D, Kawecka M, Pytlak B, Walewski J, Prochorec-Sobieszek M. Szumera-CieĆkiewicz A, et al. Among authors: sokol k. Anticancer Res. 2020 Dec;40(12):6685-6697. doi: 10.21873/anticanres.14692. Anticancer Res. 2020. PMID: 33288562
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.
Sokolowska O, Rodziewicz-Lurzynska A, Pilch Z, Kedzierska H, Chlebowska-Tuz J, Sosnowska A, Szumera-Cieckiewicz A, Sokol K, Barankiewicz J, Salomon-Perzynski A, Ciepiela O, Lech-Maranda E, Golab J, Nowis D. Sokolowska O, et al. Among authors: sokol k. Clin Exp Med. 2023 Sep;23(5):1563-1572. doi: 10.1007/s10238-022-00878-1. Epub 2022 Aug 31. Clin Exp Med. 2023. PMID: 36044158 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34701013
133 results